Future therapies in the management of critically ill AIDS patients.
The advent of antiviral therapy for HIV infection and anti-infective agents for the treatment and prophylaxis of Pneumocystis carinii pneumonia has had a significant impact on the survival and quality of life of persons with AIDS and associated conditions. This article discusses zidovudine and other antiviral therapies for HIV infection, as well as some of the new treatment and prophylactic strategies to manage opportunistic infections which can ameliorate the course of advanced HIV infection in patients who may require critical care.
Torres
R A
RA
AIDS Center, St. Vincent's Hospital and Medical Center, New York, New York.
Franke-Ruta
G
G
Barr
M R
MR
D017088:AIDS-Related Opportunistic Infections / Q000628:therapy; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy*; D000998:Antiviral Agents / Q000145:classification / Q000627:therapeutic use; D003422:Critical Care / Q000379:methods / Q000639:trends*; D016207:Cytokines / Q000627:therapeutic use; D005544:Forecasting; D006801:Humans; D009705:Nucleosides / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors
D000998:Antiviral Agents; D016207:Cytokines; D009705:Nucleosides; D011480:Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors